Biocon | Business Upturn

Latest Articles

Biocon signs out-licensing deal with Ajanta Pharma to market Semaglutide in overseas markets

Corporates · Dec 23, 2025

blank

Biocon Biologics secures full global rights for Hulio biosimilar Adalimumab

Corporates · Dec 23, 2025

blank

Biocon shares rise jump 2% after US FDA issues VAI status for New Jersey facility

Stock Market · Dec 19, 2025

blank

Biocon launches Liraglutide for diabetes and obesity in the Netherlands

Corporates · Dec 15, 2025

blank

Top stocks to watch today, December 8: Ola Electric, IndiGo, Biocon, Ashoka Buildcon, Cochin Shipyard and more

Stock Market · Dec 8, 2025

blank

Biocon Biologics secures market pathway for Denosumab Biosimilars in Europe following settlement with Amgen

Corporates · Dec 2, 2025

blank

Biocon Biologics’ bengaluru facility receives ‘VAI’ classification from US FDA

Corporates · Nov 27, 2025

blank

Biocon shares fall sharply over 3% as Citi downgrades stock to ‘Sell’ with target price of Rs 360

Stock Market · Nov 20, 2025

blank

Biocon subsidiary gets U.S. FDA approval for Tofacitinib Extended-Release tablets

Stock Market · Nov 19, 2025

blank

Top Q2 results today, November 11: Bajaj Finserv, Biocon, Tata Power, RVNL, Hindustan Copper and more to announce earnings

Quarterly Results · Nov 11, 2025

blank

Top stocks to watch today, October 23: DRL, BEL, Biocon, TVS Motor, Tata Motors, and more

Stock Market · Oct 23, 2025

blank

Biocon Biologics gets Health Canada approval for Yesintek

Stock Market · Oct 23, 2025

blank

Biocon subsidiary, in partnership with Carnegie Pharmaceuticals, gets USFDA tentative nod for Rifaximin Tablets 550 mg

Corporates · Oct 7, 2025

blank

Biocon Biologics secures U.S. launch for Bosaya and Aukelso following settlement with Amgen

Corporates · Oct 1, 2025

blank

Top stocks to watch today, September 19: Adani Group, NTPC, JSW Energy, Vedanta, Biocon, Waaree Energies and more

Stock Market · Sep 19, 2025

Showing 15 of 70 articles